Researchers have developed an AI image generator that produces images in just four steps, rather than dozens. This could bring fast, private image generation directly to consumer devices. When you ...

Claude can now generate visuals when producing a response. (Anthropic) With Claude enjoying a moment of newfound popularity among regular people, Anthropic is previewing an update designed to make its ...

BRENTWOOD, N.H., March 12, 2026 (GLOBE NEWSWIRE) -- Enhanced platform now fits nearly 4,000 generator models and delivers independently tested protection up to 110 mph winds, 18 inches of rain per ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...

Generate Biomedicines Inc. raised $400 million in an initial public offering, pricing its shares at the midpoint of the marketed range. The Somerville, Massachusetts-based drug developer sold 25 ...

Google just debuted Nano Banana 2, an updated version of its AI image generator. It combines the abilities of Google’s previous release, Nano Banana Pro—like text rendering and web searching—with ...

Google rolled out Nano Banana 2 on Thursday, an update to its viral AI image generator. The newest model will have increased speed, enhanced text renderings and follow instructions more precisely. The ...

I recently saw a tweet showing how Google has acquired companies over the years and built products around them. Here is the link to the tweet if you want. Now, Google made another announcement: Google ...

Generate:Biomedicines is hoping to raise up to $425 million via a Nasdaq IPO, with the proceeds needed to bankroll its lead antibody through respiratory disease trials. The Flagship Pioneering-founded ...

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...